Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMMA-SLEEP: GHB for Sleep Disorders in ICU Patients
NCT07596342Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in sleep disorder, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
sodium oxybate
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT07596342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596342.